Genomic landscape of acquired resistance to targeted therapies in patients with solid tumors: A study from the National Center for Precision Medicine (PRISM)

被引：0
|
作者：
Bayle, Arnaud
Belcaid, Laila
Cousin, Sophie
Palmieri, Lola-Jade
Spalato, Mariella
Aldea, Mihaela
Vasseur, Damien
Alame, Melissa
Soubeyran, Isabelle
Nicotra, Claudio
Ngocamus, Maud
Ponce, Santiago
Loriot, Yohann
Besse, Benjamin
Lacroix, Ludovic
Rouleau, Etienne
Oxnard, Geoffrey R.
Barlesi, Fabrice
Andre, Fabrice
Italiano, Antoine
机构：
[1] Gustave Roussy Canc Ctr, Villejuif, France
[2] Rigshospitalet, Copenhagen, Denmark
[3] Inst Bergonie, Early Phase Clin Trials Unit & Thorac Unit, Bordeaux, France
[4] Inst Bergonie, Bordeaux, France
[5] Gustave Roussy, Dept Canc Med, Villejuif, France
[6] Gustave Roussy, Villejuif, France
[7] Inst Bergonie, Dept Biopathol, Mol Pathol Unit, Bordeaux, France
[8] Gustave Roussy, Drug Dev Dept DITEP, Villejuif, France
[9] Gustave Roussy, DITEP Drug Dev Dept, Villejuif, France
[10] Univ Paris Saclay, Gustave Roussy, DITEP, Villejuif, France
[11] Gustave Roussy, Dept Pathol & Med Biol, Canc Genet Lab, Villejuif, France
[12] Fdn Med, Cambridge, MA USA
[13] Univ Paris Sud, Gustave Roussy, Villejuif, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3016
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Nationwide precision oncology pilot study: KOrean Precision Medicine Networking Group Study of MOlecular profiling-guided therapy based on genomic alterations in advanced solid tumors (KOSMOS) KCSG AL-20-05
    Kim, T-Y
    Kim, S. Y.
    Kim, J. H.
    Jung, H. A.
    Choi, Y. J.
    Hwang, I. G.
    Cha, Y.
    Lee, G-W
    Lee, Y-G
    Kim, T. M.
    Lee, S-H
    Lee, S.
    Yun, H.
    Choi, Y. L.
    Yoon, S.
    Han, S. W.
    Kim, T. W.
    Zang, D. Y.
    Kang, J. H.
    ESMO OPEN, 2024, 9 (10)
  • [32] Regorafenib in Patients With Solid Tumors With BRAF Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
    Sahai, Vaibhav
    Rothe, Michael
    Mangat, Pam K.
    Garrett-Mayer, Elizabeth
    Suhag, Vijay
    Dib, Elie G.
    Mehmi, Inderjit
    Kadakia, Kunal C.
    Pisick, Evan
    Duvivier, Herbert L.
    Le, Phat
    Li, Rui
    Michelin, David P.
    Wilcox, Ryan E.
    Grantham, Gina N.
    Hinshaw, Dominique C.
    Gregory, Abigail
    Halabi, Susan
    Schilsky, Richard L.
    JCO PRECISION ONCOLOGY, 2024, 8
  • [33] Korean Precision Medicine Networking Group study of molecular profiling guided therapy based on genomic alterations in advanced solid tumors (KOSMOS) II (KCSG AL 22-09)
    Kim, Sun Young
    Kim, Jee Hyun
    Kim, Tae-Yong
    Park, Sook Ryun
    Yoon, Shinkyo
    Lee, Soohyeon
    Lee, Se-Hoon
    Kim, Tae Min
    Han, Sae-Won
    Yun, Hongseok
    Lee, Sejoon
    Kim, Jihun
    Choi, Yoon-La
    Choi, Kui Son
    Chae, Heejung
    Ryu, Hyewon
    Lee, Gyeong-Won
    Zang, Dae Young
    Ahn, Joong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [34] Establishment of a Biobank of Patient-Derived Orthoxenografts from Pediatric Solid Tumors Within a Single-Center Precision Medicine Program. Results After 4 Years
    Guillen Burrieza, G.
    Soriano, A.
    Hladun, R.
    Lopez-Fernandez, S.
    Roma, J.
    Segura, M. F.
    Garrido, M.
    Villanueva, A.
    Gallego, S.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S430 - S430
  • [35] Final clinical outcomes of nationwide precision oncology pilot study; KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS) KCSG AL-20-05
    Kim, T-Y.
    Kim, S. Y.
    Kim, J. H.
    Jung, H. A.
    Choi, Y. J.
    Hwang, I. G.
    Cha, Y.
    Lee, G-W.
    Lee, Y-G.
    Kim, T. M.
    Lee, S-H.
    Lee, S.
    Yun, H.
    Choi, Y-L.
    Yoon, S.
    Han, S-W.
    Kim, T-Y.
    Kim, T. W.
    Zang, D. Y.
    Kang, J. H.
    ANNALS OF ONCOLOGY, 2023, 34 : S490 - S491
  • [36] Mutation-targeted T cell responses in blood from patients with solid tumors prior to treatment and which evolve with clinical benefit from anti-PD-1 therapies
    Yuen, Benjamin
    Yin, Fangfang
    An, Duo
    Quach, Boi
    Guo, Linlin
    Tan, Joanne
    Peng, Songming
    Pan, Zheng
    Dalmas, Olivier
    Bao, Robert
    Jacoby, Kyle
    Sennino, Barbara
    Mandl, Stefanie
    Walters, Matt
    Jaen, Juan
    Franzusoff, Alex
    Yuen, Benjamin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [37] Determine the impact of hybrid capture-based comprehensive genomic profiling (CGP) on the treatment strategies in patients with solid tumors: A national, multicenter, retrospective study.
    Disel, Umut
    Kose, Fatih
    Bilici, Ahmet
    Ozguroglu, Mustafa
    Saglam, Sezer
    Seker, Mesut
    Aksoy, Sercan
    Tek, Ibrahim
    Eralp, Yesim
    Mandel, Nil Molinas
    Demir, Gokhan
    Arslan, Cagatay
    Demiray, Mutlu
    Salepci, Taflan
    Ozturk, Mehmet Akif
    Selcukbiricik, Fatih
    Temizas, Gokce
    Fidan, Ebru Gul
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [38] Nivolumab Plus Ipilimumab in Patients With Solid Tumors With ATM Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
    Rohatgi, Nitin
    Rothe, Michael
    Mangat, Pam K.
    Garrett-Mayer, Elizabeth
    Meric-Bernstam, Funda
    Pisick, Evan
    Alese, Olatunji B.
    Reynolds, Christopher M.
    Thota, Ramya
    Vaccaro, Gina M.
    von Mehren, Margaret
    Arend, Rebecca C.
    Chiu, Vi K.
    Duvivier, Herbert L.
    Gold, Philip J.
    Hack, Keely
    Marr, Alissa S.
    Winer, Arthur
    Grantham, Gina N.
    Hinshaw, Dominique C.
    Gregory, Abigail
    Halabi, Susan
    Schilsky, Richard L.
    JCO PRECISION ONCOLOGY, 2023, 7
  • [39] Talazoparib in Patients With Solid Tumors With BRCA1/2 Mutation: Results From the Targeted Agent and Profiling Utilization Registry Study
    Srkalovic, Gordan
    Rothe, Michael
    Mangat, Pam K.
    Garrett-Mayer, Elizabeth
    Ahn, Eugene R.
    Brouse, Gregory
    Chan, John
    Mehmi, Inderjit
    Khalil, Maya
    Duvivier, Herbert L.
    Gaba, Anu
    Leuva, Harshraj
    Thota, Ramya
    Yost, Kathleen J.
    Grantham, Gina N.
    Gregory, Abigail
    Hinshaw, Dominique C.
    Halabi, Susan
    Schilsky, Richard L.
    JCO PRECISION ONCOLOGY, 2024, 8
  • [40] Talazoparib in Patients With Solid Tumors With BRCA1/2 Mutation: Results From the Targeted Agent and Profiling Utilization Registry Study
    Srkalovic, Gordan
    Rothe, Michael
    Mangat, Pam K.
    Garrett-Mayer, Elizabeth
    Ahn, Eugene R.
    Brouse, Gregory
    Chan, John
    Mehmi, Inderjit
    Khalil, Maya
    Duvivier, Herbert L.
    Gaba, Anu
    Leuva, Harshraj
    Thota, Ramya
    Yost, Kathleen J.
    Grantham, Gina N.
    Gregory, Abigail
    Hinshaw, Dominique C.
    Halabi, Susan
    Schilsky, Richard L.
    JCO PRECISION ONCOLOGY, 2024, 8
12345